# Precise Light Surgical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/precise-light-surgical

- Industry: Medical Devices & Equipment
- Headquarters: Campbell, US
- Website: www.preciselightsurgical.com
- Total disclosed funding: $4.5M
- Latest round: Series A (Oct 1, 2013)
- Investors on record: 1

## About

Precise Light Surgical Inc. specializes in innovative surgical solutions, enhancing surgical precision through advanced technologies that optimize patient outcomes and improve operational efficiency in medical environments.Precise Light Surgical Inc. focuses on developing advanced surgical technologies. The company is headquartered in Campbell, US. Richard Nash is the founder and CEO, having previously founded other companies. In May 2018, Precise Light Surgical raised USD 4.59 mn in Series B funding, achieving a total amount raised of USD 4.59 mn and a current company valuation of USD 34.17 mn. The company has completed 4 deals as of the latest funding event.Precise Light Surgical Inc. offers a range of surgical technologies designed to enhance precision and safety in surgical procedures. These products are tailored to meet the needs of healthcare professionals, providing tools that improve the accuracy of surgical interventions and reduce recovery times for patients. The solutions cater to various medical fields, ensuring advanced capabilities that address the growing demands of the healthcare sector.The company's revenue model is primarily based on the sale of their surgical technologies, which are marketed to healthcare facilities and professionals. Precise Light Surgical Inc. generates income through direct sales of its products and partnerships with distributors, ensuring a steady flow of revenue as demand for innovative surgical solutions continues to rise.Precise Light Surgical Inc. plans to leverage the recent Series B funding of USD 4.59 mn to accelerate the development of new surgical products aimed at improving patient outcomes. The company is targeting expansion into international markets, particularly in Europe and Asia, by 2025. Upcoming product launches are anticipated to include next-generation surgical instruments and enhanced technology platforms, which align with the company's commitment to advancing surgical precision and operational efficiency.

## Funding rounds

- Series A, Oct 1, 2013, $4.5M — Easton Capital Investment Group

## Investors

- Easton Capital Investment Group (https://capitalatlas.ai/funds/easton-capital-investment-group) — Series A